BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 6785399)

  • 1. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
    Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
    Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
    Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
    Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
    J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
    Fogelman I; Greig WR; Bessent RG; Boyle IT
    J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
    [No Abstract]   [Full Text] [Related]  

  • 6. Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements.
    Fogelman I; Bessent R; Scullion JE; Cuthbert GF
    Eur J Nucl Med; 1982; 7(8):359-63. PubMed ID: 6811274
    [No Abstract]   [Full Text] [Related]  

  • 7. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
    Smith ML; Martin W; Fogelman I; Bessent RG
    J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
    Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
    J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
    Molloi S; Mazess R; Bendsen H; Wilson M
    Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
    Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
    Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diphosphonates in the evaluation of metabolic bone disease.
    Fogelman I; Smith ML
    Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
    Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
    J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 99mTc-diphosphonate whole-body retention measurements using a conic-beam collimator and a scintillation detector.
    Vattimo A
    J Nucl Med Allied Sci; 1987; 31(3):291-4. PubMed ID: 3121810
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
    Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
    J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.
    Hyldstrup L
    Dan Med Bull; 1989 Sep; 36(4):349-58. PubMed ID: 2509145
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
    Blake GM; Moore AE; Fogelman I
    Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
    Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
    Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurements of the distribution of technetium-99m sulfur colloid and technetium-99m HEDP in normal humans.
    Grossman LW; Sodd VJ; Nishiyama H; Feller PA; Hoops RG
    Med Phys; 1983; 10(1):79-82. PubMed ID: 6405144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
    Fogelman I; Bessent R
    J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
    Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
    J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.